Skip to main content

Main menu

  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Collections
    • Podcast
  • ALERTS
  • FOR AUTHORS
    • Information for Authors
    • Fees
    • Journal Clubs
    • eLetters
    • Submit
  • EDITORIAL BOARD
  • ABOUT
    • Overview
    • Advertise
    • For the Media
    • Rights and Permissions
    • Privacy Policy
    • Feedback
  • SUBSCRIBE

User menu

  • Log in
  • My Cart

Search

  • Advanced search
Journal of Neuroscience
  • Log in
  • My Cart
Journal of Neuroscience

Advanced Search

Submit a Manuscript
  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Collections
    • Podcast
  • ALERTS
  • FOR AUTHORS
    • Information for Authors
    • Fees
    • Journal Clubs
    • eLetters
    • Submit
  • EDITORIAL BOARD
  • ABOUT
    • Overview
    • Advertise
    • For the Media
    • Rights and Permissions
    • Privacy Policy
    • Feedback
  • SUBSCRIBE
PreviousNext
Research Articles, Neurobiology of Disease

Neurophysiological and Brain Structural Markers of Cognitive Frailty Differ from Alzheimer's Disease

Ece Kocagoncu, David Nesbitt, Tina Emery, Laura E. Hughes, Richard N. Henson, James B. Rowe and Cambridge Center for Ageing and Neuroscience
Journal of Neuroscience 16 February 2022, 42 (7) 1362-1373; DOI: https://doi.org/10.1523/JNEUROSCI.0697-21.2021
Ece Kocagoncu
1Department of Clinical Neurosciences, University of Cambridge, Cambridge, CB2 0SZ, United Kingdom
2MRC Cognition and Brain Sciences Unit, University of Cambridge, Cambridge, CB2 7EF, United Kingdom
4Cambridge University Hospital NHS Foundation Trust, University of Cambridge, Cambridge, CB2 2QQ, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David Nesbitt
1Department of Clinical Neurosciences, University of Cambridge, Cambridge, CB2 0SZ, United Kingdom
2MRC Cognition and Brain Sciences Unit, University of Cambridge, Cambridge, CB2 7EF, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tina Emery
2MRC Cognition and Brain Sciences Unit, University of Cambridge, Cambridge, CB2 7EF, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Laura E. Hughes
1Department of Clinical Neurosciences, University of Cambridge, Cambridge, CB2 0SZ, United Kingdom
2MRC Cognition and Brain Sciences Unit, University of Cambridge, Cambridge, CB2 7EF, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Laura E. Hughes
Richard N. Henson
2MRC Cognition and Brain Sciences Unit, University of Cambridge, Cambridge, CB2 7EF, United Kingdom
3Department of Psychiatry, University of Cambridge, Cambridge, CB2 0SZ, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Richard N. Henson
James B. Rowe
1Department of Clinical Neurosciences, University of Cambridge, Cambridge, CB2 0SZ, United Kingdom
2MRC Cognition and Brain Sciences Unit, University of Cambridge, Cambridge, CB2 7EF, United Kingdom
4Cambridge University Hospital NHS Foundation Trust, University of Cambridge, Cambridge, CB2 2QQ, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for James B. Rowe
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

With increasing life span and prevalence of dementia, it is important to understand the mechanisms of cognitive aging. Here, we focus on a subgroup of the population we term “cognitively frail,” defined by reduced cognitive function in the absence of subjective memory complaints, or a clinical diagnosis of dementia. Cognitive frailty is distinct from cognitive impairment caused by physical frailty. It has been proposed to be a precursor to Alzheimer's disease, but may alternatively represent one end of a nonpathologic spectrum of cognitive aging. We test these hypotheses in humans of both sexes, by comparing the structural and neurophysiological properties of a community-based cohort of cognitive frail adults, to people presenting clinically with diagnoses of Alzheimer's disease or mild cognitive impairment, and community-based cognitively typical older adults. Cognitive performance of the cognitively frail was similar to those with mild cognitive impairment. We used a novel cross-modal paired-associates task that presented images followed by sounds, to induce physiological responses of novelty and associative mismatch, recorded by EEG/MEG. Both controls and cognitively frail showed stronger mismatch responses and larger temporal gray matter volume, compared with people with mild cognitive impairment and Alzheimer's disease. Our results suggest that community-based cognitively frail represents a spectrum of normal aging rather than incipient Alzheimer's disease, despite similar cognitive function. Lower lifelong cognitive reserve, hearing impairment, and cardiovascular comorbidities might contribute to the etiology of the cognitive frailty. Critically, community-based cohorts of older adults with low cognitive performance should not be interpreted as representing undiagnosed Alzheimer's disease.

SIGNIFICANCE STATEMENT The current study investigates the neural signatures of cognitive frailty in relation to healthy aging and Alzheimer's disease. We focus on the cognitive aspect of frailty and show that, despite performing similarly to the patients with mild cognitive impairment, a cohort of community-based adults with poor cognitive performance do not show structural atrophy or neurophysiological signatures of Alzheimer's disease. Our results call for caution before assuming that cognitive frailty represents latent Alzheimer's disease. Instead, the cognitive underperformance of cognitively frail adults could result in cumulative effects of multiple psychosocial risk factors over the lifespan, and medical comorbidities.

  • aging
  • Alzheimer's disease
  • cognitive frailty
  • cognitive reserve
  • MEG
  • MRI

Introduction

With longer life span and an older population, there is a pressing need to understand the mechanisms that determine cognitive aging, and its relationship to dementias. The cognitively frail is a population of interest, defined by reduced cognitive function in the absence of subjective memory complaints, or a clinical diagnosis of dementia, mild cognitive impairment (MCI), or other preexisting neurologic explanation. Here cognitive frailty does not refer only to the cognitive impairments of those with comorbid physical frailty (Kelaiditi et al., 2013). Cognitive frailty has been linked to a higher risk of dementia, and is often regarded as a precursor to Alzheimer's disease (Panza et al., 2006; Buchman et al., 2007; Kojima et al., 2016; Shimada et al., 2018). In the absence of physical frailty, cognitive impairment alone is associated with longitudinal decline in functional abilities, activities of daily living (Shimada et al., 2016), increased hospitalization, and all-cause mortality rate (Avila-Funes et al., 2012; Solfrizzi et al., 2012; Ge et al., 2020).

However, there is an alternative hypothesis: poor cognitive performance reflects adverse aspects of normal aging, without latent Alzheimer's disease or other neurodegenerative process. Psychosocial, educational, medical factors may contribute to cognitive frailty in the absence of latent degenerative or vascular dementia pathologies. For example, cognitively underperforming adults are 4 times more likely to come from disadvantaged socioeconomic backgrounds, and twice as likely to have lower educational qualifications (Rogers et al., 2017). They are more likely to be malnourished (Mulero et al., 2011; Talegawkar et al., 2012; Chye et al., 2018), have a sedentary lifestyle (Landi et al., 2010; Rogers et al., 2017), and have more medical comorbidities, such as cardiovascular disease (Patrick et al., 2002; Langlois et al., 2012; Fuhrmann et al., 2019), chronic inflammation (Walston et al., 2002; Weaver et al., 2002; Cappola et al., 2003), and hearing impairment (Valentijn et al., 2005; Panza et al., 2015).

Here we determine whether cognitively frail community dwelling older adults have structural and/or neurophysiological characteristics of normal aging or early Alzheimer's disease. We quantify brain structure and function using MRI and EEG/MEG respectively. In Alzheimer's disease, amyloid plaques and neurofibrillary tangles form early in entorhinal cortex and hippocampi (Hardy and Selkoe, 2002; Braak et al., 2006), leading to disruptions in synaptic and neural function (LaFerla and Oddo, 2005; West and Bhugra, 2015) and atrophy. If the cognitively frail have prodromal or undiagnosed Alzheimer's disease pathology, one would expect similar structural and neurophysiological changes. To assess the neural systems of hippocampal-dependent associative memory, we designed the cross-modal oddball task. The trials consisted of repeated pairings of an abstract image with a sound. A mismatch response arose from pairs that included either a novel sound (i.e., novelty deviant [DN]) or a sound that was not novel but had been previously associated with a different image (i.e., associative deviant [DA]). The DNs are akin to typical mismatch negativity responses, proposed to be an index of auditory predictive coding, which is attenuated in Alzheimer's disease (Ruzzoli et al., 2016; Laptinskaya et al., 2018). The DAs are a more sensitive test of Alzheimer's disease, since hippocampal dysfunction would impair the ability to establish cross-modal associations (Gottfried and Dolan, 2003; Joassin et al., 2011), and attenuate the response to DAs. Indeed, previous studies report impaired performance on the paired-associates learning task in MCI and preclinical Alzheimer's disease, which correlates with disease progression (Blackwell et al., 2004; Ahmed et al., 2008). Moreover, in fMRI, paired-associates learning task shows Alzheimer's-related increased hippocampal activity and connectivity between hippocampus and cortical areas (de Rover et al., 2011; Harrison et al., 2016). We measured DN and DA responses in lateral frontotemporal areas, readily detected by EEG/MEG in auditory oddball paradigms and reduced in dementia (Pekkonen, 2000; Garrido et al., 2009; Phillips et al., 2016).

We proposed that, if cognitively frailty represents part of the spectrum of normal aging, rather than latent Alzheimer's disease, then the neurophysiological responses and structural features of cognitively frail adults would resemble cognitively healthy adults rather than the patients with MCI or Alzheimer's disease.

Materials and Methods

Study design

The Cambridge Center for Ageing and Neuroscience (Cam-CAN) Frail Project is an extension of the large-scale cross-sectional population-based Cam-CAN (Shafto et al., 2014), focused on cognitive frailty. It examines the subpopulation of community-dwelling adults with cognitive frailty, identified from home screening visits by cognitive screening tests: below 25/30 on the Mini Mental State Examination (MMSE) and/or below 88/100 on the Addenbrooke's Cognitive Examination–Revised (ACE-R) in the absence of a diagnosis or referral for a memory disorder.

The Cam-CAN Frail protocol comprised of three sessions. First, a visit to the participant's home to assess lifestyle, health, and cognitive performance on an extensive neuropsychological test battery. The battery included the ACE-R, MMSE, Wechsler Adult Intelligence Scale logical memory test, Spot the Word test, simple choice reaction time, famous faces test, four-mountains task, virtual object location and orientation, Rey figure recall, and the trail making test. In the second session, participants underwent EEG/MEG scanning and completed the Cattell and digit symbol tests. During the EEG/MEG recording, participants completed the cross-modal oddball task. In the final session, participants had an fMRI and structural MRI and completed the Hotel task. The study was approved by the East of England–Cambridge Central Research Ethics Committee (10/H0308/50).

Participants

Participants consisted of community-dwelling older healthy controls, and patients diagnosed with either MCI or Alzheimer's disease by secondary healthcare services (Table 1). The cognitively frail individuals were defined by underperformance on cognitive tests, without any subjective memory complaints or clinical diagnosis of dementia, MCI, or other significant neurologic and psychiatric illness. A group of cognitively frail adults was recruited from the participants who had been assessed at home as part of the Cam-CAN 3000 home assessment (Shafto et al., 2014), but who had not been recruited into the Cam-CAN 700 or Cam-CAN 280 reassessments. These healthy cognitive controls scored >25/30 on MMSE or >88/100 on the ACE-R during the home interview. The Cam-CAN home visits acquired lifestyle and cardiovascular risk characteristics (alcohol and smoking, hypertension, history of stroke and heart attack).

View this table:
  • View inline
  • View popup
Table 1.

Demographic and cognitive screening results for the four study populationsa

In addition, patients were recruited from local specialist memory clinics who had MCI or probable Alzheimer's disease diagnosed according to Petersen and McKhann criteria, respectively (McKhann et al., 2011; Petersen et al., 2014). Most MCI/AD patients had positive CSF biomarker status for Alzheimer's disease pathology, or clinical follow-up to confirm the diagnosis. Participants were recruited from either sex, were older than 50 years, and were fluent speakers in English, with mental capacity to consent. Participants did not have any significant psychiatric illness or established neurologic condition (other than MCI or Alzheimer's disease in the patient groups).

EEG/MEG and MRI acquisition

We used EEG/MEG to quantify neurophysiological dysfunction, as used in studies of healthy successful aging (Vlahou et al., 2014; Tsvetanov et al., 2015; Coquelet et al., 2017; Price et al., 2017), and early signatures of MCI and Alzheimer's disease (Osipova et al., 2005; Stam et al., 2006; de Haan et al., 2012; Maestú et al., 2015; Hughes et al., 2019; Kocagoncu et al., 2020). EEG/MEG data were acquired using the Elekta Vector View system with 204 planar gradiometers and 102 magnetometers. Simultaneous EEG data were acquired using a 70-channel Easycap. Participants' horizontal and vertical eye movements, and the cardiac activity were recorded using bipolar electro-oculogram and electro-cardiogram electrodes. Five head position indicator coils were placed on the EEG cap, to track the head position every 200 ms. For coregistration of the participant's T1-weighted MRI scan to the MEG sensors, three fiducial points (nasion, left, and right pre-auricular) and a minimum of 100 head shape points were digitized using Polhemus digitization.

Participants were seated in a magnetically shielded room (IMEDCO) and positioned under the MEG scanner. Auditory stimuli were delivered binaurally through MEG-compatible ER3A insert earphones (Etymotic Research). The delay in sound delivery because of the length of earphone tubes and sound card was 26 ± 2 ms on average. Visual stimuli were presented on the screen positioned 1.22 m in front of the participant's visual field. Simultaneous EEG/MEG was recorded continuously at 1000 Hz with a high-pass filter of 0.03 Hz. Before the EEG/MEG recording, participants performed an automated hearing test in the MEG scanner, to make sure that the earphones were working properly. They were presented pure tones at the frequency of 1000 Hz to either ear with varying loudness. Participants were instructed to press the button when they heard the tone. The mean hearing levels of each group are given in Table 1, where the normal range is expected to fall within 45-75 dB.

T1-weighted structural images were acquired on a Siemens 3T Magnetom Prisma MRI Scanner using an MPRAGE sequence (TR = 2250 ms, TE = 2.99 ms; inversion time = 900 ms; flip angle = 9 degrees; FOV = 256 mm × 240 mm × 192 mm; voxel size = 1 mm isotropic; GRAPPA acceleration factor = 2; acquisition time = 4 min 32 s). Four participants did not tolerate MRI because of claustrophobia.

Stimuli

The stimuli consisted of abstract images and pure tones. There were four images with distinct patterns. The tones had the following frequencies: 503, 719, 1021, and 1451 Hz. Harmonic tones were avoided by choosing frequencies of prime numbers and varying them by at least three semi-tones. There were four types of trials. (1) Standard (STD) trials were image-tone pairs that participants trained on before the task. STD pairs were the trials presented most frequently. (2) DA trials presented the same images of the STD pairs but by shuffling the sounds. The DA trials were expected to capture the binding effect arising from a mismatch in association. (3) DN trials presented the STD images with rare deviant tones. The frequencies used for the DNs were 599, 857, 1017, and 1733 Hz. The DN trials were expected to capture the novelty effect, and were essentially the deviants used in conventional mismatch paradigms. The deviant trials were expected to induce a mismatch response with respect to the response to STD trials. (4) Target trials: The STD pairs, where the image was bound by a red circle. Target trials were included to make sure participants were attending to the stimuli. There were in total 1000 STD trials; and DA, DN, and target trials were presented 48 times each. Therefore, the DA, DN, and the targets were each encountered 4% of the time each, whereas STDs 88% of the time.

Paradigm

The cross-modal oddball paradigm depends on both change detection and associative binding. This has two advantages. First, as MEG recording has lower signal-to-noise ratio in the subcortical areas and deeper sources compared with signal coming from superficial cortices (Goldenholz et al., 2009), the task was specifically designed to capture the indirect response in the superior temporal gyri (STG) and inferior frontal gyri (IFG), which are dependent on hippocampal associative learning. Second, the integrity of the auditory and frontal cortex is preserved until late stages of Alzheimer's disease, allowing us to control for atrophy of the cortical generators of the mismatch response. The task was easy to perform both by all participant groups and required minimal training (reducing potential confounds, e.g., education and cognitive strategies on performance).

Images were presented centrally on a gray screen bounded by a black circle for 800 ms. Then, 300 ms after image onset, the tone was played for 500 ms (see Fig. 1A). The 300 ms lag was introduced to allow participants to form predictions about the upcoming auditory stimuli. In between trials, a black fixation square was presented for a jittered period of 300-500 ms, resulting in a stimulus onset asynchrony between 1000 and 1200 ms. E-Prime 2 (Psychology Software Tools) was used to present the stimuli and send triggers to the scanner.

In the training phase, participants were presented in total four images and four tones (i.e., STD pairs), 25 times each, and were instructed to try to remember the pairings between the images and the tones. After the training, participants performed a short test where they listened to the four tones twice in a randomized order. After each tone, they were shown four images (i.e., chance level of 25%) on the screen and were asked to select the image that was paired with that tone. Irrespective of the participant's performance, training was repeated only once. Following the training, participants moved on to the main task. Trials were presented in a different randomized order for each participant across four 5-min-long blocks. Participants were instructed to pay attention to the images and press the button with their right index finger when the image was bound by a red circle.

EEG/MEG preprocessing and source localization

The raw EEG/MEG data were preprocessed using MaxFilter 2.2.12 (Elekta Oy). MaxFiltering included detection and interpolation of bad sensors, signal space separation to remove external noise from the data, and head movement correction. Cardiac and blink artifacts were detected and removed using an independent component analysis with 800 maximum steps and 64 principal components via the EEGLAB toolbox (Delorme and Makeig, 2004). The independent component time series were correlated with EOG and ECG time series and spatial templates. The components that revealed higher than z = 3 in the temporal and z = 2 in the spatial dimension were removed, and the remaining time series of the independent components were reconstructed. On average, 2.38 blink components (SD = 0.58) and 1.30 cardiac components (SD = 0.49) were removed.

Data were further processed in SPM12 (www.fil.ion.ucl.ac.uk/spm). Data were bandpass filtered between 0 and 40 Hz using a fifth-order Butterworth filter. The continuous data were epoched between −100 and 500 ms from the sound onset. OSL's artifact rejection algorithm (www.github.com/OHBA-analysis/osl-core) was used to remove remaining artifacts (e.g., motor). Bad channels and trials marked by the algorithm were removed. On average, 53.04 (4.6%; SD = 35.88) trials and 10.76 channels (2.8%; SD = 5.85) were removed per participant. Trials were averaged within condition, using robust averaging. Low-pass filter was reapplied to correct for the high-frequency noise introduced by robust averaging.

The EEG/MEG data were source localized using all sensor data: magnetometers, gradiometers, and EEG (Henson et al., 2009). The source space was modeled with a medium-sized cortical mesh consisting of 8196 vertices via inverse normalization of SPM's canonical meshes. Sensor positions were coregistered to the native T1-weighted MPRAGE scans using the fiducial and head shape points after removing digitization points around the nose. SPM's canonical template brain was used for participants who did not tolerate the MRI scan. Single shell and Boundary Element models were used for forward modeling of MEG and EEG data, respectively. Evoked signal was estimated over the trials using the COH solution in SPM, which imposes spatial smoothness on the prior covariance matrix. All inversion accuracies were >80%, as measured by the proportion of variance explained in the sensor data (mean = 93.62; SD = 3.63).

Although neurophysiological responses in the hippocampus are difficult to detect with EEG/MEG, owing to its depth, a strong mismatch response can be recorded from temporal cortex, where sensory predictions are assumed to be established from hippocampal-dependent cross-modal associative learning. We therefore focus on the mismatch response in the lateral temporal auditory and frontal cortex, as activated in conventional auditory oddball paradigms (Pekkonen, 2000; Garrido et al., 2009; Hughes and Rowe, 2013; Phillips et al., 2016; Hughes et al., 2018). The source localized data were extracted from six areas taken from the Automated Anatomical Labeling atlas: Heschl's gyrus (HG), STG, and IFG bilaterally (see Fig. 2C). The ROI masks were resliced to 1 mm isotropic thickness to allow maximum data extraction. For each participant and condition, the data were extracted from the peak within all the vertices that constitute each ROI. This is to maximize the signal-to-noise ratio in the data, and to account for individual variability in source activity. We had two contrasts of interest in the analyses: the STD-DN contrast captures the novelty mismatch effect, whereas the STD-DA contrast captures the associative mismatch effect.

MRI preprocessing and gray matter analysis

The T1 image was rigid-body coregistered to an MNI template and then corrected for image inhomogeneity and segmented into six tissue classes (gray matter, white matter, CSF, bone, soft tissue, and residual noise) using SPM's unified segmentation algorithm (Ashburner and Friston, 2005). The native space gray and white matter images for all participants were then submitted to diffeomorphic registration (DARTEL) (Ashburner, 2007) to create group template images. The group template was then normalized to the MNI template via an affine transformation, and the combined normalization parameters (native to group template and group template to MNI template) were applied to each individual participant's gray matter image, including modulation to preserve local volume. ROIs from the Harvard-Oxford atlas were then used to extract mean regional GMV from the bilateral hippocampal and entorhinal ROIs for each participant. The GMVs were compared across groups using ANCOVAs where age and total intracranial volume (TIV) were set as covariates.

To calculate local gray matter atrophy at the whole-brain level, we used voxel-based morphometry. Gray matter segments were thresholded with an absolute masking level of 0.1, and were smoothed with a Gaussian kernel at 8 mm FWHM. Gray matter volumes (GMVs) were compared across groups in pairwise t contrasts in GLMs accounting for differences in age and TIV. The cluster level p values were corrected for multiple comparisons using the familywise error after a cluster defining threshold of p < 0.05.

Root mean square (RMS) and statistical analyses

To investigate differences in time series, the RMS of the time series at each ROI and trial were smoothed using a moving average at every 50 time points, to remove jumps. The RMS at each time point was then modeled using GLMs accounting for differences in age and hearing levels, and tested for within-group task effects by using t contrasts. The contrasts compared the signal intensity between the DA-STD and DN-STD. The tests comparing the deviant effects were performed first within each participant group, to reveal task-specific effects. Second, these differences were tested across groups to test for interaction effects between conditions and groups. The observed cluster masses in the GLMs were corrected for multiple comparisons using permutation cluster statistics, by bootstrapping the design matrix using 1000 permutations at p = 0.05. The mean of the time series within each contrast was calculated for each participant within the 200-500 ms time window after removing outliers. This time window was selected because task effects were strongest after the N100. The linear relationship between these metrics and predictor variables was further tested through GLMs across the sample, including age as a covariate, and after removing outliers. The predictors of interest were years of education, ACE-R total and memory subscale scores, and hippocampal and entorhinal GMVs.

Results

Sample characteristics

Sample characteristics and scores on neuropsychological tests were compared across the groups using ANOVAs. Age (F(3,87) = 3.82; p = 0.012) and years of education (F(3,87) = 11.34; p < 0.001) differed between groups. Tukey's HSD tests showed that the cognitively frail group was older than controls (p = 0.006). The duration of formal education was longer in those in the control group than the cognitively frail (p < 0.001), and Alzheimer's disease group (p = 0.032). The MCI group had had longer education than the cognitively frail (p < 0.001) and Alzheimer's disease (p = 0.001) groups. Hearing levels were tested for group differences using both ANOVA and ANCOVA (to control for differences in age). There were no significant differences in hearing in the left ear. In the right ear, there was a group difference (F(3,86) = 4.70; p = 0.004): the hearing of the cognitively frail was lower than control (p = 0.017) and MCI (p = 0.005) groups. When adjusting for the differences in age (F(3,85) = 3.02; p = 0.034), the hearing levels on the right were still lower in the cognitively frail group compared with the MCI group (p = 0.019). χ2 tests compared the prevalence of lifestyle and cardiovascular risk factors between control and the cognitively frail groups. The prevalence of daily alcohol consumption was lower in the cognitively frail group (19%) compared with controls (43%) (χ2(1) = 6.11; p = 0.006). The prevalence of hypertension was higher in the cognitively frail group (52%) compared with the controls (35%) (χ2(1) = 2.74; p = 0.048). There were no significant differences between groups in the prevalence of smoking, history of stroke, or heart attack.

Cognitive results

Cognitive scores were tested for group differences after controlling for differences in age (Table 1). The MMSE (F(3,86) = 17.64; p < 0.001), ACE-R total score (F(3,86) = 55.41; p < 0.001), ACE-R's subscales in memory (F(3,86) = 37.35; p < 0.001), attention (F(3,86) = 9.05; p < 0.001), fluency (F(3,86) = 13.87; p < 0.001), language (F(3,86) = 7.90; p < 0.001), and visuospatial skills (F(3,86) = 11.15; p < 0.001) showed strong differences across the groups (Fig. 1A). Results of the pairwise post hoc comparisons are given in Figure 1B. The cognitively frail group performed similarly to the MCI group across all cognitive tests, except for the fluency subscale, where their scores were significantly lower than the MCI group (p < 0.001). All four groups performed above chance level on the training test. The scores were significantly different across groups (F(3,86) = 5.60; p = 0.001). Post hoc comparisons showed that the controls performed significantly better than the MCI (p = 0.015) and Alzheimer's disease (p = 0.006) groups. There were no significant differences between the training scores of the cognitively frail group and other groups.

Figure 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1.

A, Radar chart represents the group means for the neuropsychological tests converted to percentages against the maximum score in each test for ease of comparison across groups. The performance of the cognitively frail group overlaps with the MCI across all tests except for ACE-R fluency. B, Group differences in education levels and neuropsychological tests. The cognitively frail group had lower education levels than the controls. On the neuropsychological tests, the cognitively frail performed similar to the MCI group. C, Example stimuli from the cross-modal oddball task. The images were presented together with paired sounds after the 300 ms lag. Participants were asked to press the button whenever they saw a red circle around the image. MCI, Symptomatic MCI after secondary/tertiary memory clinic assessment.

Gray matter atrophy

Mean hippocampal GMV, entorhinal GMV, total GMV, and TIV were compared across the groups, corrected for age and TIV using ANCOVA. There were no significant differences between groups for TIV or total GMV. However, hippocampal (F(3,86) = 10.35; p < 0.001) and entorhinal (F(3,86) = 7.62; p < 0.001) GMVs showed a main group effect (Fig. 2A,B). The hippocampal GMV in the control group was significantly larger compared with the MCI (p < 0.001) and Alzheimer's disease groups (p < 0.001). Similarly, the entorhinal GMV of the control group was larger compared with the MCI (p = 0.001) and Alzheimer's disease groups (p = 0.003). The hippocampal and entorhinal volumes of the cognitively frail group were similar to the control group.

Figure 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 2.

A, B, GMV differences across groups in the hippocampus and entorhinal cortex. Boxplots represent the normalized residuals after correcting for differences in age and TIV. There were no significant differences in volume between the cognitively frail and the control group. C, Six ROIs used in the RMS analysis. ROIs comprise IFG, STG, and HG bilaterally. D, E, The contrast images from the voxel-based morphometry analysis. Control and the cognitively frail show similar patterns of GMV compared with the MCI and Alzheimer's disease groups. For the GMV analysis of the lateral frontotemporal ROIs used in the RMS analysis, see Extended Data Figure 2-1. MCI, Symptomatic MCI after secondary/tertiary memory clinic assessment.

Figure 2-1

Gray matter volume analysis of the lateral frontotemporal network. In Alzheimer's disease. atrophy of the auditory cortex comes at the later isocortical Braak stages (i.e., V-VI) along with other neocortical areas such as the frontal cortex. Therefore, in the early stages of Alzheimer's disease, the integrity of the auditory cortex is not expected to be compromised, and consequently, diminished deviant responses observed in our clinical population are not expected be attributed to the atrophied auditory cortex. To provide support for this claim, we performed the confirmatory GMV comparisons across the four groups within the lateral frontotemporal ROIs which were used to extract neurophysiological signals from. We performed ANCOVAs to test for group differences while accounting for differences in age and TIV. As expected, there were no significant effect of the group in any of the six ROIs, confirming that the differences we find in the deviant responses could not be attributed to local GM atrophy. C, Controls; F, cognitively frail; AD, Alzheimer's disease. Download Figure 2-1, TIF file.

Atrophy was tested at the voxel level, using voxel-based morphometry (Table 2). As expected, the control group had significantly higher GMV in bilateral temporal cortices and hippocampi compared with the MCI and AD. We found a similar pattern comparing cognitively frail group to MCI and Alzheimer's disease group, although cluster extents were smaller (Fig. 2D,E). In order to confirm that the differences we observe in the neurophysiological responses could be because of local GM atrophy of the lateral frontotemporal areas, we tested the GMV of the lateral frontotemporal areas bilaterally (i.e., IFG, STG, HG), and report that the GMVs of the superficial areas do not differ across groups (Extended Data Fig. 2-1).

View this table:
  • View inline
  • View popup
Table 2.

Voxel-based morphometry of volume differences between groupsa

Cross-modal mismatch responses

Figure 3A-D displays the gradiometer topoplots for each condition in 100 ms time windows across the groups. Following N100, topoplots represent a strong burst of bilateral activity in frontal and temporal sensors that is sustained until the end of the epoch. Compared with the DA and STD, DN induced a stronger and more widespread activity across the frontotemporal sensors. The gradiometer topoplots are given here for visualization only; statistical comparisons were made in the a priori source space ROIs.

Figure 3.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 3.

DA and DN responses by group. A-D, Topoplots represent the mean gradiometer activity across the scalp for the DA, DN, and STD conditions in 100 ms time windows in four groups. The DN amplitude is higher after the N100 peak, compared with both DA and STD conditions in control and cognitively frail groups. The gradiometer activity in the MCI and Alzheimer's disease groups is weaker compared with the control and cognitively frail groups. E, Plots represent the RMS time series for the left hemisphere ROIs for simplicity. Dashed vertical lines indicate the sound onset. The amplitude differences between the deviants and the STD in the frontal regions were larger than the temporal regions, and the deviant effects are stronger in the control and cognitively frail groups; and there is considerably higher variance in the MCI group. For the renderings of the source activity, see Extended Data Figure 3-1. Amp, Amplitude; AU, arbitrary units; fT, femtotesla; LHG, left HG; LIFG, left IFG; LSTG, left STG.

Figure 3-1

Source activity: The renderings display mean source activity in 100 ms moving time windows in the Control group. In line with the topoplot activity and our RMS findings, here we find the activation of a bilateral frontotemporal network peaking at 100 ms. Further, compared with the STD condition, deviant conditions show stronger and more widespread activity in the frontotemporal regions 200 ms after the sound onset. Download Figure 3-1, TIF file.

We tested the time series of each deviant with respect to the STD, within the 6 ROIs (Table 3; Fig. 3E). We found strongest effects for the DN in the bilateral IFG early in the epoch, following the onset of the sound. The effects seen in the cognitively frail group mirrored the controls. Further, DN effects were found across all the ROIs in the control group. MCI and Alzheimer's disease groups showed no significant novelty effects in the IFG, and weaker clusters limited to STG and HG. DA effects were found in the IFG across all groups, and in overlapping time windows starting at ∼200 ms after the sound onset.

View this table:
  • View inline
  • View popup
Table 3.

Regional differences in the response to DN and DA compared with STD trialsa

Supplementary Material

Supplementary Table 3-1

[ns-JN-RM-0697-21-s03.docx]

We tested for the interaction effects between the deviant responses (i.e., STD-DA, and STD-DN) and group. There was no significant interaction between the control and cognitively frail group or between MCI and Alzheimer's disease groups. However, the control group showed stronger DA and DN responses compared with both MCI and Alzheimer's disease groups. Similarly, the cognitively frail group showed the same interaction effects against the MCI and Alzheimer's disease groups. As a confirmatory analysis, we also repeated these GLMs with log-transformed squared RMS time series to ensure that the normality assumption is met. These results can be found in Extended Data Table 3-1.

Clinical and structural correlates of the cross-modal mismatch

To assess how the deviant responses relate to clinical severity, education, and medial temporal lobe atrophy, the linear relationships between the EEG/MEG contrast means at 200-500 ms and each predictor variable were tested using GLMs (Fig. 4A) while controlling for differences in age. This revealed strong relationships between the DN mean in the left HG and right HG with ACE-R total and ACE-R-memory subscale scores: the higher the scores on cognitive tests, the more negative (toward normal) the DN was. A strong negative relationship between the hippocampal and entorhinal volumes and the deviant response was observed for the left hemisphere ROIs, particularly the left HG. This suggests that medial temporal atrophy is associated with a reduced deviant response, although the mismatch negativity response arises from extrahippocampal auditory cortex. This negative relationship was stronger for the DN compared with the DA. Education showed moderate positive relationships with the DA in the left STG and right STG, whereas it showed a negative relationship with the DN mean in right IFG.

Figure 4.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 4.

Neurophysiological responses are related to clinical and volumetric differences between individuals. A, The t-map displays the GLM results across predictors and DA and DN mean responses for each ROI. White squares represent significant effects. The effects are stronger for the LHG across the ROIs, and for the DN compared with the DA. B, Scatterplots represent the negative relationship between the DA and DN means in the LHG with the hippocampal GMV across the sample. ACE-R mem, ACE-R memory subscale; ENT, entorhinal GMV; HIP, hippocampal GMV; LHG, left HG; LIFG, left IFG; LSTG, left STG; RHG, right HG; RSTG, right STG; RIFG, right IFG; YOE, years of education.

We calculated the partial correlations among predictor variables correcting for differences in age. Education showed positive correlations with ACE-R total (r = 0.40; p < 0.001) and ACE-R memory subscale scores (r = 0.35; p = 0.001), but did not correlate with hippocampal and entorhinal volumes. ACE-R total score correlated with both hippocampal (r = 0.53; p < 0.001) and entorhinal GMV (r = 0.40; p < 0.001). Similarly, ACE-R memory subscale score positively correlated with hippocampal (r = 0.55; p < 0.001) and entorhinal GMV (r = 0.41; p < 0.001).

Discussion

The principal result of this study is that community-dwelling cognitively frail individuals do not resemble people with MCI or Alzheimer's disease, in terms of their structural or neurophysiological profile, despite similar levels of underperformance on cognitive screening tests. The poor cognitive performance of the cognitively frail participants should not simply be interpreted arising from latent Alzheimer pathology or undiagnosed amnestic MCI. Population screening using standard cognitive tests (e.g., MMSE, or ACE-R) is therefore unlikely to selectively identify those with latent Alzheimer's disease pathology without additional biomarker evidence of pathology. There are other associations of cognitive impairment, including lower educational level, hearing impairment, and cardiovascular risk factors. Both structural and neurophysiological features of the cognitively frail group were similar to controls. Structural analyses revealed a higher GMV in the latero-medial temporal cortices bilaterally in the control and cognitively frail compared with MCI and Alzheimer's disease groups. Like the controls, the cognitively frail showed stronger DA and DN responses compared with MCI or Alzheimer's disease in relation to hippocampal and entorhinal volumes.

The cross-modal oddball task was designed to induce deviant responses from the superficial frontotemporal cortex, as neurophysiological markers of hippocampal-dependent associative learning. Alzheimer's patients show impairments in both sensory and associative memory, reduced medial temporal lobe activity to novelty (Sperling et al., 2003; Dickerson et al., 2005), and reduced electrophysiological response to oddballs (Engeland et al., 2002; Lee et al., 2013; Ruzzoli et al., 2016). We confirmed that Alzheimer's patients show reduced DA and DN responses. Neurophysiological profiles of the control and cognitively frail overlapped, and were significantly stronger compared with MCI and Alzheimer's disease groups. Task effects of the DN responses were observed across all ROIs for the control and cognitively frail. The group-task interaction effects showing stronger DA and DN responses for the controls and cognitively frail were located in right Heschl's, bilateral superior temporal, and IFG. In other words, the neuropsychologically impaired cognitively frail group does not show the neurophysiological signatures of early Alzheimer's disease. From a theoretical perspective, it is interesting to note that the response associated with DAs was weaker than DNs, and did not differ qualitatively in terms of timing or distribution across our ROIs. We had expected the DA response to be more hippocampal-dependent, and hence more impaired with Alzheimer's pathology, but our current analyses suggest it was qualitatively similar to the more typical DN response.

To explore the differences between the community-based cognitively frail and Alzheimer's disease or MCI, we tested volumetric differences in medial temporal lobe. Structurally, early Alzheimer's disease is characterized by atrophy in the medial temporal lobe as a function of tau burden (Braak et al., 2006; Schwarz et al., 2016). Recent studies of cognitive frailty have suggested frontotemporal and subcortical atrophy (Del Brutto et al., 2017; Gallucci et al., 2018), increased white matter hyperintensities (Avila-Funes et al., 2017; Del Brutto et al., 2017; Sugimoto et al., 2019), and decreased white matter microstructure integrity (Avila-Funes et al., 2017). We did not find structural differences between the control and cognitively frail in medial temporal lobe structures. The community-based groups showed significantly larger hippocampus and entorhinal volumes compared with patients with MCI and Alzheimer's disease, and did not show early structural signatures of Alzheimer's disease. The difference between our study and the previous work may lie in the epidemiological approach to baseline recruitment through the Cam-CAN 3000 cohort, rather than clinical referral pathways.

The neuropsychological profile of the cognitively frail resembled MCI group. They scored lower than the healthy controls on every ACE-R subscale. Compared with the MCI patients, they were more impaired on fluency, which might indicate an underlying executive deficit. Previous studies have suggested that the neuropsychological profile of cognitive frailty differs from MCI in episodic memory with domains of language, visuospatial skills, and executive function relatively spared (Collie and Maruff, 2000). The cognitive impairment profile in frail adults has been described in terms of deficits in executive function and attention. Frail adults tend to not use cues effectively to retrieve stored information (Canevelli et al., 2015; Delrieu et al., 2016), have slower reaction times (O'Halloran et al., 2014; Robertson et al., 2014), show lower meta-cognitive awareness, and show error monitoring (Amanzio et al., 2017).

However, many previous studies have focused on cognitive impairment in the context of physical frailty, rather than defining cognitive frailty in terms of poor cognitive function in a nonclinical community-dwelling cohort. The cognitive underperformance of our cognitively frail might partly be attributed to their shorter education, coupled with a bias in most cognitive tests toward the better educated (Huppert et al., 2005). That is, highly educated individuals perform better on cognitive tests, such as MMSE and ACE-R, unless scores are normalized by education (Crane et al., 2006; Mathuranath et al., 2007; Amaral-Carvalho and Caramelli, 2012).

Our findings support the hypothesis that cognitive frailty represents part of the spectrum of normal neurocognitive function, rather than incipient Alzheimer's disease. This conclusion calls for a reevaluation of the prior findings that associate cognitive frailty with higher incidence of dementia and faster cognitive decline (Buchman et al., 2007; Kojima et al., 2016; Shimada et al., 2018). These former studies have quantified the dementia incidence, including all subtypes of dementia; however, this association was highest in non-Alzheimer's dementias, particularly for vascular dementia (Panza et al., 2006; Avila-Funes et al., 2012; Gray et al., 2013; Aguilar-Navarro et al., 2016; Solfrizzi et al., 2017a). Although the link between cognitive frailty and Alzheimer's disease in previous studies is not conclusive, the two entities might share common risk factors, such as cardiovascular disease (Panza et al., 2006; Frisoli et al., 2015; Fuhrmann et al., 2019) and hearing impairment (Valentijn et al., 2005; Panza et al., 2015).

In addition to the cardiovascular risk factors (Newman et al., 2001; Patrick et al., 2002; Fuhrmann et al., 2019), the cognitive underperformance of our cognitively frail group could be a result of cumulative effects of multiple psychosocial and medical risk factors. Malnutrition (Mulero et al., 2011; Chye et al., 2018; Rietman et al., 2018), social isolation (Robertson et al., 2013), sedentary lifestyle (Landi et al., 2010), lack of intellectual cognitive activities (Jung et al., 2010), psychiatric illnesses and long-term use of antidepressants (Paulson and Lichtenberg, 2013; Gray et al., 2015), chronic inflammation (Weaver et al., 2002; Solfrizzi et al., 2017b), and lower education levels (Rogers et al., 2017) are known risk factors affecting healthy aging. Here, the cognitively frail group had significantly lower education levels compared with the controls and MCI. This is a common pattern observed in other frailty studies (Brigola et al., 2019; Margioti et al., 2020). The cognitively frail population have significantly lower occurrence of third-level education (Robertson et al., 2014), and are twice as likely to have no educational qualifications (Rogers et al., 2017). Further, strong association between educational level and frailty was linked to mediating socioeconomic, behavioral, and psychosocial factors, such as low income, chronic diseases, obesity, depression, unhealthy lifestyle, and chronic stress (Hoogendijk et al., 2014). This is consistent with the cognitive reserve hypothesis that an individual's prior education and cognitive abilities modify the resilience of brain structure to disease and injury (Stern, 2002). Longer education in early life and continuing diverse cognitive leisure activities in midlife and old age contribute to an individual's cognitive reserve, and is related to better cognitive functioning in old age (Singh-Manoux et al., 2011; Borgeest et al., 2018; Lavrencic et al., 2018; Brigola et al., 2019) and having fewer symptoms of cognitive decline and neuropathology (Mortimer et al., 2003; Chapko et al., 2018).

The study has several limitations. Because of the cross-sectional design of the study, we are unable to quantify the rates of progression or conversion to dementia from cognitive frailty. Longitudinal cognitive and neuroimaging studies would be useful to confirm the rate of conversion to Alzheimer's disease or other dementia, and potential mediators of conversion. Further, this study did not incorporate Alzheimer's disease biomarkers and instead used clinical criteria and neuropsychological criteria to define the groups. The cognitively frail group was defined using a standard threshold on ACE-R and MMSE. Future studies investigating the link between cognitive frailty and Alzheimer's disease may test for biomarkers of Alzheimer's, such as tau and amyloid-β measures acquired from blood, CSF, or positron emission tomography. Future studies may also assess the polygenic risk for Alzheimer's disease using common (e.g., APOE) and rare variants associated with the disease, which would help disentangle environmental and psychosocial risk factors from genetic risk factors contributing to cognitive frailty's etiology. Further work is needed to clarify genetic and pathology-based features of cognitive frailty in relation to Alzheimer's disease and other dementias.

Our findings provide new evidence that community-dwelling cognitively frail older adults are neurophysiologically and structurally similar to those with more successful cognitive aging, without the structural or neurophysiological features of MCI or Alzheimer's disease, despite similarly poor cognitive function to MCI. Their underperformance on cognitive tests may be because of lower cognitive reserve and other risk factors across the lifespan.

Footnotes

  • This work was supported by Medical Research Council SUAG/004 RG91365, SUAG/046 RG101400, and SUAG/051 RG101400; Wellcome Trust 103838; Dementias Platform UK MR/L023784/1 and MR/L023784/2; Alzheimer's Research UK ARUK-PG2017B-19; Holt Fellowship; and National Institute for Health Research Cambridge Biomedical Research Center BRC-1215-20014. The views expressed are those of the authors and not necessarily those of the National Institute for Health Research or the Department of Health and Social Care. For the purpose of open access, the author has applied a CC BY public copyright license to any author accepted manuscript version arising from this submission.

  • The authors declare no competing financial interests.

  • Correspondence should be addressed to Ece Kocagoncu at ece.kocagoncu{at}cantab.net

This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license, which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed.

References

  1. ↵
    1. Aguilar-Navarro SG,
    2. Mimenza-Alvarado AJ,
    3. Anaya-Escamilla A,
    4. Gutiérrez-Robledo LM
    (2016) Frailty and vascular cognitive impairment: mechanisms behind the link. Rev Invest Clin 68:25–32. pmid:27028174
    OpenUrlPubMed
  2. ↵
    1. Ahmed S,
    2. Mitchell J,
    3. Arnold R,
    4. Nestor PJ,
    5. Hodges JR
    (2008) Predicting rapid clinical progression in amnestic mild cognitive impairment. Dement Geriatr Cogn Disord 25:170–177. doi:10.1159/000113014 pmid:18212499
    OpenUrlCrossRefPubMed
  3. ↵
    1. Amanzio M,
    2. Palermo S,
    3. Zucca M,
    4. Rosato R,
    5. Rubino E,
    6. Leotta D,
    7. Bartoli M,
    8. Rainero I
    (2017) Neuropsychological correlates of pre-frailty in neurocognitive disorders: a possible role for metacognitive dysfunction and mood changes. Front Med (Lausanne) 4:199. doi:10.3389/fmed.2017.00199 pmid:29188218
    OpenUrlCrossRefPubMed
  4. ↵
    1. Amaral-Carvalho V,
    2. Caramelli P
    (2012) Normative data for healthy middle-aged and elderly performance on the Addenbrooke Cognitive Examination–Revised. Cogn Behav Neurol 25:72–76. doi:10.1097/WNN.0b013e318259594b
    OpenUrlCrossRefPubMed
  5. ↵
    1. Ashburner J
    (2007) A fast diffeomorphic image registration algorithm. Neuroimage 38:95–113. doi:10.1016/j.neuroimage.2007.07.007 pmid:17761438
    OpenUrlCrossRefPubMed
  6. ↵
    1. Ashburner J,
    2. Friston KJ
    (2005) Unified segmentation. Neuroimage 26:839–851. doi:10.1016/j.neuroimage.2005.02.018 pmid:15955494
    OpenUrlCrossRefPubMed
  7. ↵
    1. Avila-Funes JA,
    2. Carcaillon L,
    3. Helmer C,
    4. Carrière I,
    5. Ritchie K,
    6. Rouaud O,
    7. Tzourio C,
    8. Dartigues JF,
    9. Amieva H
    (2012) Is frailty a prodromal stage of vascular dementia? Results from the Three-City Study. J Am Geriatr Soc 60:1708–1712. doi:10.1111/j.1532-5415.2012.04142.x pmid:22985143
    OpenUrlCrossRefPubMed
  8. ↵
    1. Avila-Funes JA,
    2. Pelletier A,
    3. Meillon C,
    4. Catheline G,
    5. Periot O,
    6. Trevin O-Frenk I,
    7. Gonzalez-Colaço M,
    8. Dartigues JF,
    9. Pérès K,
    10. Allard M,
    11. Dilharreguy B,
    12. Amieva H
    (2017) Vascular cerebral damage in frail older adults: the AMImage study. J Gerontol A Biol Sci Med Sci 72:971–977. doi:10.1093/gerona/glw347 pmid:28329104
    OpenUrlCrossRefPubMed
  9. ↵
    1. Blackwell AD,
    2. Sahakian BJ,
    3. Vesey R,
    4. Semple JM,
    5. Robbins TW,
    6. Hodges JR
    (2004) Detecting dementia: novel neuropsychological markers of preclinical Alzheimer's disease. Dement Geriatr Cogn Disord 17:42–48. doi:10.1159/000074081
    OpenUrlCrossRefPubMed
  10. ↵
    1. Borgeest GS,
    2. Henson RN,
    3. Shafto M,
    4. Samu DC,
    5. Kievit R
    (2018) Greater lifestyle engagement is associated with better cognitive resilience. PsyArXiv.
  11. ↵
    1. Braak H,
    2. Alafuzoff I,
    3. Arzberger T,
    4. Kretzschmar H,
    5. Del Tredici K
    (2006) Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol 112:389–404. doi:10.1007/s00401-006-0127-z pmid:16906426
    OpenUrlCrossRefPubMed
  12. ↵
    1. Brigola AG,
    2. Alexandre TD,
    3. Inouye K,
    4. Yassuda MS,
    5. Pavarini SC,
    6. Mioshi E
    (2019) Limited formal education is strongly associated with lower cognitive status, functional disability and frailty status in older adults. Dement Neuropsychol 13:216–224. doi:10.1590/1980-57642018dn13-020011 pmid:31285797
    OpenUrlCrossRefPubMed
  13. ↵
    1. Buchman AS,
    2. Boyle PA,
    3. Wilson RS,
    4. Tang Y,
    5. Bennett DA
    (2007) Frailty is associated with incident Alzheimer's disease and cognitive decline in the elderly. Psychosom Med 69:483–489. doi:10.1097/psy.0b013e318068de1d pmid:17556640
    OpenUrlAbstract/FREE Full Text
  14. ↵
    1. Canevelli M,
    2. Cesari M,
    3. van Kan GA
    (2015) Frailty and cognitive decline: how do they relate? Curr Opin Clin Nutr Metab Care 18:43–50. doi:10.1097/MCO.0000000000000133 pmid:25405314
    OpenUrlCrossRefPubMed
  15. ↵
    1. Cappola AR,
    2. Xue QL,
    3. Ferrucci L,
    4. Guralnik JM,
    5. Volpato S,
    6. Fried LP
    (2003) Insulin-like growth factor I and interleukin-6 contribute synergistically to disability and mortality in older women. J Clin Endocrinol Metab 88:2019–2025. doi:10.1210/jc.2002-021694 pmid:12727948
    OpenUrlCrossRefPubMed
  16. ↵
    1. Chapko D,
    2. McCormack R,
    3. Black C,
    4. Staff R,
    5. Murray A
    (2018) Life-course determinants of cognitive reserve (CR) in cognitive aging and dementia: a systematic literature review. Aging Ment Health 22:915–926. doi:10.1080/13607863.2017.1348471 pmid:28703027
    OpenUrlCrossRefPubMed
  17. ↵
    1. Chye L,
    2. Wei K,
    3. Nyunt MS,
    4. Gao Q,
    5. Wee SL,
    6. Ng TP
    (2018) Strong relationship between malnutrition and cognitive frailty in the Singapore Longitudinal Ageing Studies (SLAS-1 and SLAS-2). J Prev Alzheimers Dis 5:1–148. doi:10.14283/jpad.2017.46
    OpenUrlCrossRef
  18. ↵
    1. Collie A,
    2. Maruff P
    (2000) The neuropsychology of preclinical Alzheimer's disease and mild cognitive impairment. Neurosci Biobehav Rev 24:365–374. doi:10.1016/S0149-7634(00)00012-9 pmid:10781696
    OpenUrlCrossRefPubMed
  19. ↵
    1. Coquelet N,
    2. Mary A,
    3. Peigneux P,
    4. Goldman S,
    5. Wens V,
    6. De Tiège X
    (2017) The electrophysiological connectome is maintained in healthy elders: a power envelope correlation MEG study. Sci Rep 7:13984. doi:10.1038/s41598-017-13829-8 pmid:29070789
    OpenUrlCrossRefPubMed
  20. ↵
    1. Crane PK,
    2. Gibbons LE,
    3. Jolley L,
    4. van Belle G,
    5. Selleri R,
    6. Dalmonte E,
    7. De Ronchi D
    (2006) Differential item functioning related to education and age in the Italian version of the Mini-Mental State Examination. Int Psychogeriatr 18:505–515. doi:10.1017/S1041610205002978 pmid:16478571
    OpenUrlCrossRefPubMed
  21. ↵
    1. de Haan W,
    2. van der Flier WM,
    3. Wang H,
    4. Van Mieghem PF,
    5. Scheltens P,
    6. Stam CJ
    (2012) Disruption of functional brain networks in Alzheimer's disease: what can we learn from graph spectral analysis of resting-state magnetoencephalography? Brain Connect 2:45–55. doi:10.1089/brain.2011.0043 pmid:22480296
    OpenUrlCrossRefPubMed
  22. ↵
    1. Del Brutto OH,
    2. Mera RM,
    3. Cagino K,
    4. Fanning KD,
    5. Milla-Martinez MF,
    6. Nieves JL,
    7. Zambrano M,
    8. Sedler MJ
    (2017) Neuroimaging signatures of frailty: a population-based study in community-dwelling older adults (the Atahualpa Project). Geriatr Gerontol Int 17:270–276. doi:10.1111/ggi.12708 pmid:26790541
    OpenUrlCrossRefPubMed
  23. ↵
    1. Delorme A,
    2. Makeig S
    (2004) EEGLAB: an open source toolbox for analysis of single-trial EEG dynamics including independent component analysis. J Neurosci Methods 134:9–21. doi:10.1016/j.jneumeth.2003.10.009 pmid:15102499
    OpenUrlCrossRefPubMed
  24. ↵
    1. Delrieu J,
    2. Andrieu S,
    3. Pahor M,
    4. Cantet C,
    5. Cesari M,
    6. Ousset PJ,
    7. Voisin T,
    8. Fougère B,
    9. Gillette S,
    10. Carrie I,
    11. Vellas B
    (2016) Neuropsychological profile of 'cognitive frailty' subjects in MAPT study. J Prev Alzheimers Dis 3:151–159. doi:10.14283/jpad.2016.94 pmid:27547746
    OpenUrlCrossRefPubMed
  25. ↵
    1. de Rover M,
    2. Pironti VA,
    3. McCabe JA,
    4. Acosta-Cabronero J,
    5. Arana FS,
    6. Morein-Zamir S,
    7. Hodges JR,
    8. Robbins TW,
    9. Fletcher PC,
    10. Nestor PJ,
    11. Sahakian BJ
    (2011) Hippocampal dysfunction in patients with mild cognitive impairment: a functional neuroimaging study of a visuospatial paired associates learning task. Neuropsychologia 49:2060–2070. doi:10.1016/j.neuropsychologia.2011.03.037 pmid:21477602
    OpenUrlCrossRefPubMed
  26. ↵
    1. Dickerson BC,
    2. Salat DH,
    3. Greve DN,
    4. Chua EF,
    5. Rand-Giovannetti E,
    6. Rentz DM,
    7. Bertram L,
    8. Mullin K,
    9. Tanzi RE,
    10. Blacker D,
    11. Albert MS,
    12. Sperling RA
    (2005) Increased hippocampal activation in mild cognitive impairment compared to normal aging and AD. Neurology 65:404–411. doi:10.1212/01.wnl.0000171450.97464.49 pmid:16087905
    OpenUrlAbstract/FREE Full Text
  27. ↵
    1. Engeland C,
    2. Mahoney C,
    3. Mohr E,
    4. Ilivitsky V,
    5. Knott VJ
    (2002) Acute nicotine effects on auditory sensory memory in tacrine-treated and nontreated patients with Alzheimer's disease: an event-related potential study. Pharmacol Biochem Behav 72:457–464. doi:10.1016/S0091-3057(02)00711-6 pmid:11900820
    OpenUrlCrossRefPubMed
  28. ↵
    1. Frisoli A,
    2. Ingham SJ,
    3. Paes Â,
    4. Tinoco E,
    5. Greco A,
    6. Zanata N,
    7. Pintarelli V,
    8. Elber I,
    9. Borges J,
    10. Camargo Carvalho AC
    (2015) Frailty predictors and outcomes among older patients with cardiovascular disease: data from Fragicor. Arch Gerontol Geriatr 61:1–7. doi:10.1016/j.archger.2015.03.001 pmid:25921097
    OpenUrlCrossRefPubMed
  29. ↵
    1. Fuhrmann D,
    2. Nesbitt D,
    3. Shafto M,
    4. Rowe JB,
    5. Price D,
    6. Gadie A,
    7. Kievit RA
    , Cambridge Center for Ageing and Neuroscience (2019) Strong and specific associations between cardiovascular risk factors and white matter micro- and macrostructure in healthy aging. Neurobiol Aging 74:46–55. doi:10.1016/j.neurobiolaging.2018.10.005 pmid:30415127
    OpenUrlCrossRefPubMed
  30. ↵
    1. Gallucci M,
    2. Piovesan C,
    3. Di Battista ME
    (2018) Associations between the Frailty Index and Brain Atrophy: the Treviso Dementia (TREDEM) Registry. J Alzheimers Dis 62:1623–1634. doi:10.3233/JAD-170938 pmid:29504533
    OpenUrlCrossRefPubMed
  31. ↵
    1. Garrido MI,
    2. Kilner JM,
    3. Stephan KE,
    4. Friston KJ
    (2009) The mismatch negativity: a review of underlying mechanisms. Clin Neurophysiol 120:453–463. doi:10.1016/j.clinph.2008.11.029 pmid:19181570
    OpenUrlCrossRefPubMed
  32. ↵
    1. Ge ML,
    2. Carlson MC,
    3. Bandeen-Roche K,
    4. Chu NM,
    5. Tian J,
    6. Kasper JD,
    7. Xue QL
    (2020) U.S. national profile of older adults with cognitive impairment alone, physical frailty alone, and both. J Am Geriatr Soc 68:2822–2830. doi:10.1111/jgs.16769 pmid:32860219
    OpenUrlCrossRefPubMed
  33. ↵
    1. Goldenholz DM,
    2. Ahlfors SP,
    3. Hämäläinen MS,
    4. Sharon D,
    5. Ishitobi M,
    6. Vaina LM,
    7. Stufflebeam SM
    (2009) Mapping the signal-to-noise-ratios of cortical sources in magnetoencephalography and electroencephalography. Hum Brain Mapp 30:1077–1086. doi:10.1002/hbm.20571 pmid:18465745
    OpenUrlCrossRefPubMed
  34. ↵
    1. Gottfried JA,
    2. Dolan RJ
    (2003) The nose smells what the eye sees: crossmodal visual facilitation of human olfactory perception. Neuron 39:375–386. doi:10.1016/s0896-6273(03)00392-1 pmid:12873392
    OpenUrlCrossRefPubMed
  35. ↵
    1. Gray SL,
    2. Anderson ML,
    3. Hubbard RA,
    4. LaCroix A,
    5. Crane PK,
    6. McCormick W,
    7. Bowen JD,
    8. McCurry SM,
    9. Larson EB
    (2013) Frailty and incident dementia. J Gerontol A Biol Sci Med Sci 68:1083–1090. doi:10.1093/gerona/glt013 pmid:23419778
    OpenUrlCrossRefPubMed
  36. ↵
    1. Gray SL,
    2. Anderson ML,
    3. Dublin S,
    4. Hanlon JT,
    5. Hubbard R,
    6. Walker R,
    7. Yu O,
    8. Crane PK,
    9. Larson EB
    (2015) Cumulative use of strong anticholinergics and incident dementia: a prospective cohort study. JAMA Intern Med 175:401–407. doi:10.1001/jamainternmed.2014.7663 pmid:25621434
    OpenUrlCrossRefPubMed
  37. ↵
    1. Hardy J,
    2. Selkoe DJ
    (2002) The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297:353–356. doi:10.1126/science.1072994 pmid:12130773
    OpenUrlAbstract/FREE Full Text
  38. ↵
    1. Harrison TM,
    2. Burggren AC,
    3. Small GW,
    4. Bookheimer SY
    (2016) Altered memory-related functional connectivity of the anterior and posterior hippocampus in older adults at increased genetic risk for Alzheimer's disease. Hum Brain Mapp 37:366–380. doi:10.1002/hbm.23036 pmid:26503161
    OpenUrlCrossRefPubMed
  39. ↵
    1. Henson RN,
    2. Mouchlianitis E,
    3. Friston KJ
    (2009) MEG and EEG data fusion: simultaneous localisation of face-evoked responses. Neuroimage 47:581–589. doi:10.1016/j.neuroimage.2009.04.063 pmid:19398023
    OpenUrlCrossRefPubMed
  40. ↵
    1. Hoogendijk EO,
    2. van Hout HP,
    3. Heymans MW,
    4. van der Horst HE,
    5. Frijters DH,
    6. Broese van Groenou MI,
    7. Deeg DJ,
    8. Huisman M
    (2014) Explaining the association between educational level and frailty in older adults: results from a 13-year longitudinal study in The Netherlands. Ann Epidemiol 24:538–544. doi:10.1016/j.annepidem.2014.05.002 pmid:24935466
    OpenUrlCrossRefPubMed
  41. ↵
    1. Hughes LE,
    2. Rowe JB
    (2013) The impact of neurodegeneration on network connectivity: a study of change detection in frontotemporal dementia. J Cogn Neurosci 25:802–813. doi:10.1162/jocn_a_00356 pmid:23469882
    OpenUrlCrossRefPubMed
  42. ↵
    1. Hughes LE,
    2. Rittman T,
    3. Robbins TW,
    4. Rowe JB
    (2018) Reorganization of cortical oscillatory dynamics underlying disinhibition in frontotemporal dementia. Brain 141:2486–2499. doi:10.1093/brain/awy176 pmid:29992242
    OpenUrlCrossRefPubMed
  43. ↵
    1. Hughes LE,
    2. Henson RN,
    3. Pereda E,
    4. Bruña R,
    5. López-Sanz D,
    6. Quinn AJ,
    7. Woolrich MW,
    8. Nobre AC,
    9. Rowe JB,
    10. Maestú F,
    11. Group BW
    , BioFIND Working Group (2019) Biomagnetic biomarkers for dementia: a pilot multicentre study with a recommended methodological framework for magnetoencephalography. Alzheimers Dement (Amst) 11:450–462. doi:10.1016/j.dadm.2019.04.009 pmid:31431918
    OpenUrlCrossRefPubMed
  44. ↵
    1. Huppert FA,
    2. Cabelli ST,
    3. Matthews FE
    , MRC Cognitive Function and Ageing Study (2005) Brief cognitive assessment in a UK population sample: distributional properties and the relationship between the MMSE and an extended mental state examination. BMC Geriatr 5:7. doi:10.1186/1471-2318-5-7 pmid:15869717
    OpenUrlCrossRefPubMed
  45. ↵
    1. Joassin F,
    2. Pesenti M,
    3. Maurage P,
    4. Verreckt E,
    5. Bruyer R,
    6. Campanella S
    (2011) Cross-modal interactions between human faces and voices involved in person recognition. Cortex 47:367–376. doi:10.1016/j.cortex.2010.03.003 pmid:20444445
    OpenUrlCrossRefPubMed
  46. ↵
    1. Jung Y,
    2. Gruenewald TL,
    3. Seeman TE,
    4. Sarkisian CA
    (2010) Productive activities and development of frailty in older adults. J Gerontol B Psychol Sci Soc Sci 65B:256–261. doi:10.1093/geronb/gbp105 pmid:20018794
    OpenUrlCrossRefPubMed
  47. ↵
    1. Kelaiditi E,
    2. Cesari M,
    3. Canevelli M,
    4. van Kan GA,
    5. Ousset PJ,
    6. Gillette-Guyonnet S,
    7. Ritz P,
    8. Duveau F,
    9. Soto ME,
    10. Provencher V,
    11. Nourhashemi F,
    12. Salvà A,
    13. Robert P,
    14. Andrieu S,
    15. Rolland Y,
    16. Touchon J,
    17. Fitten JL,
    18. Vellas B
    , IANA/IAGG (2013) Cognitive frailty: rational and definition from an (I.A.N.A./I.A.G.G.) international consensus group. J Nutr Health Aging 17:726–734. doi:10.1007/s12603-013-0367-2 pmid:24154642
    OpenUrlCrossRefPubMed
  48. ↵
    1. Kocagoncu E,
    2. Quinn A,
    3. Firouzian A,
    4. Cooper E,
    5. Greve A,
    6. Gunn R,
    7. Green G,
    8. Woolrich MW,
    9. Henson RN,
    10. Lovestone S,
    11. Rowe JB
    , Deep and Frequent Phenotyping Study Team (2020) Tau pathology in early Alzheimer's disease is linked to selective disruptions in neurophysiological network dynamics. Neurobiol Aging 92:141–152. doi:10.1016/j.neurobiolaging.2020.03.009 pmid:32280029
    OpenUrlCrossRefPubMed
  49. ↵
    1. Kojima G,
    2. Taniguchi Y,
    3. Iliffe S,
    4. Walters K
    (2016) Frailty as a predictor of Alzheimer disease, vascular dementia, and all dementia among community-dwelling older people: a systematic review and meta-analysis. J Am Med Dir Assoc 17:881–888. doi:10.1016/j.jamda.2016.05.013 pmid:27324809
    OpenUrlCrossRefPubMed
  50. ↵
    1. LaFerla FM,
    2. Oddo S
    (2005) Alzheimer's disease: abeta, tau and synaptic dysfunction. Trends Mol Med 11:170–176. doi:10.1016/j.molmed.2005.02.009 pmid:15823755
    OpenUrlCrossRefPubMed
  51. ↵
    1. Landi F,
    2. Abbatecola AM,
    3. Provinciali M,
    4. Corsonello A,
    5. Bustacchini S,
    6. Manigrasso L,
    7. Cherubini A,
    8. Bernabei R,
    9. Lattanzio F
    (2010) Moving against frailty: does physical activity matter? Biogerontology 11:537–545. doi:10.1007/s10522-010-9296-1 pmid:20697813
    OpenUrlCrossRefPubMed
  52. ↵
    1. Langlois F,
    2. Vu TT,
    3. Kergoat MJ,
    4. Chassé K,
    5. Dupuis G,
    6. Bherer L
    (2012) The multiple dimensions of frailty: physical capacity, cognition, and quality of life. Int Psychogeriatr 24:1429–1436. doi:10.1017/S1041610212000634 pmid:22717010
    OpenUrlCrossRefPubMed
  53. ↵
    1. Laptinskaya D,
    2. Thurm F,
    3. Küster OC,
    4. Fissler P,
    5. Schlee W,
    6. Kolassa S,
    7. von Arnim CA,
    8. Kolassa IT
    (2018) Auditory memory decay as reflected by a new mismatch negativity score is associated with episodic memory in older adults at risk of dementia. Front Aging Neurosci 10:5. doi:10.3389/fnagi.2018.00005 pmid:29456500
    OpenUrlCrossRefPubMed
  54. ↵
    1. Lavrencic LM,
    2. Richardson C,
    3. Harrison SL,
    4. Muniz-Terrera G,
    5. Keage HA,
    6. Brittain K,
    7. Kirkwood TB,
    8. Jagger C,
    9. Robinson L,
    10. Stephan BC
    (2018) Is there a link between cognitive reserve and cognitive function in the oldest-old? J Gerontol A Biol Sci Med Sci 73:499–505. doi:10.1093/gerona/glx140 pmid:28977420
    OpenUrlCrossRefPubMed
  55. ↵
    1. Lee MS,
    2. Lee SH,
    3. Moon EO,
    4. Moon YJ,
    5. Kim S,
    6. Kim SH,
    7. Jung IK
    (2013) Neuropsychological correlates of the P300 in patients with Alzheimer's disease. Prog Neuropsychopharmacol Biol Psychiatry 40:62–69. doi:10.1016/j.pnpbp.2012.08.009 pmid:22940475
    OpenUrlCrossRefPubMed
  56. ↵
    1. Maestú F,
    2. Peña JM,
    3. Garcés P,
    4. González S,
    5. Bajo R,
    6. Bagic A,
    7. Cuesta P,
    8. Funke M,
    9. Mäkelä JP,
    10. Menasalvas E,
    11. Nakamura A,
    12. Parkkonen L,
    13. López ME,
    14. Del Pozo F,
    15. Sudre G,
    16. Zamrini E,
    17. Pekkonen E,
    18. Henson RN,
    19. Becker JT
    , Magnetoencephalography International Consortium of Alzheimer's Disease (2015) A multicenter study of the early detection of synaptic dysfunction in mild cognitive impairment using magnetoencephalography-derived functional connectivity. Neuroimage Clin 9:103–109. doi:10.1016/j.nicl.2015.07.011 pmid:26448910
    OpenUrlCrossRefPubMed
  57. ↵
    1. Margioti E,
    2. Kosmidis MH,
    3. Yannakoulia M,
    4. Dardiotis E,
    5. Hadjigeorgiou G,
    6. Sakka P,
    7. Ntanasi E,
    8. Vlachos GS,
    9. Scarmeas N
    (2020) Exploring the association between subjective cognitive decline and frailty: the Hellenic Longitudinal Investigation of Aging and Diet Study (HELIAD). Aging Ment Health 24:137–147. doi:10.1080/13607863.2018.1525604 pmid:30621435
    OpenUrlCrossRefPubMed
  58. ↵
    1. Mathuranath PS,
    2. Cherian JP,
    3. Mathew R,
    4. George A,
    5. Alexander A,
    6. Sarma SP
    (2007) Mini Mental State Examination and the Addenbrooke's Cognitive Examination: effect of education and norms for a multicultural population. Neurol India 55:106–110. doi:10.4103/0028-3886.32779 pmid:17558112
    OpenUrlCrossRefPubMed
  59. ↵
    1. McKhann GM,
    2. Knopman DS,
    3. Chertkow H,
    4. Hyman BT,
    5. Jack CR,
    6. Kawas CH,
    7. Klunk WE,
    8. Koroshetz WJ,
    9. Manly JJ,
    10. Mayeux R,
    11. Mohs RC,
    12. Morris JC,
    13. Rossor MN,
    14. Scheltens P,
    15. Carrillo MC,
    16. Thies B,
    17. Weintraub S,
    18. Phelps CH
    (2011) The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 7:263–269. doi:10.1016/j.jalz.2011.03.005 pmid:21514250
    OpenUrlCrossRefPubMed
  60. ↵
    1. Mortimer JA,
    2. Snowdon DA,
    3. Markesbery WR
    (2003) Head circumference, education and risk of dementia: findings from the Nun Study. J Clin Exp Neuropsychol 25:671–679. doi:10.1076/jcen.25.5.671.14584 pmid:12815504
    OpenUrlCrossRefPubMed
  61. ↵
    1. Mulero J,
    2. Zafrilla P,
    3. Martinez-Cacha A
    (2011) Oxidative stress, frailty and cognitive decline. J Nutr Health Aging 15:756–760. doi:10.1007/s12603-011-0130-5 pmid:22089224
    OpenUrlCrossRefPubMed
  62. ↵
    1. Newman AB,
    2. Gottdiener JS,
    3. Mcburnie MA,
    4. Hirsch CH,
    5. Kop WJ,
    6. Tracy R,
    7. Walston JD,
    8. Fried LP
    , Cardiovascular Health Study Research Group (2001) Associations of subclinical cardiovascular disease with frailty. J Gerontol A Biol Sci Med Sci 56:M158–M166. doi:10.1093/gerona/56.3.M158
    OpenUrlCrossRefPubMed
  63. ↵
    1. O'Halloran AM,
    2. Finucane C,
    3. Savva GM,
    4. Robertson IH,
    5. Kenny RA
    (2014) Sustained attention and frailty in the older adult population. J Gerontol B Psychol Sci Soc Sci 69:147–156. doi:10.1093/geronb/gbt009
    OpenUrlCrossRefPubMed
  64. ↵
    1. Osipova D,
    2. Ahveninen J,
    3. Jensen O,
    4. Ylikoski A,
    5. Pekkonen E
    (2005) Altered generation of spontaneous oscillations in Alzheimer's disease. Neuroimage 27:835–841. doi:10.1016/j.neuroimage.2005.05.011 pmid:15961323
    OpenUrlCrossRefPubMed
  65. ↵
    1. Panza F,
    2. D'Introno A,
    3. Colacicco AM,
    4. Capurso C,
    5. Parigi AD,
    6. Capurso SA,
    7. Caselli RJ,
    8. Pilotto A,
    9. Scafato E,
    10. Capurso A,
    11. Solfrizzi V
    (2006) Cognitive frailty: predementia syndrome and vascular risk factors. Neurobiol Aging 27:933–940. doi:10.1016/j.neurobiolaging.2005.05.008 pmid:16023766
    OpenUrlCrossRefPubMed
  66. ↵
    1. Panza F,
    2. Solfrizzi V,
    3. Logroscino G
    (2015) Age-related hearing impairment: a risk factor and frailty marker for dementia and AD. Nat Rev Neurol 11:166–175. doi:10.1038/nrneurol.2015.12 pmid:25686757
    OpenUrlCrossRefPubMed
  67. ↵
    1. Patrick L,
    2. Gaskovski P,
    3. Rexroth D
    (2002) Cumulative illness and neuropsychological decline in hospitalized geriatric patients. Clin Neuropsychol 16:145–156. doi:10.1076/clin.16.2.145.13239 pmid:12221478
    OpenUrlCrossRefPubMed
  68. ↵
    1. Paulson D,
    2. Lichtenberg PA
    (2013) Vascular depression: an early warning sign of frailty. Aging Ment Health 17:85–93. doi:10.1080/13607863.2012.692767 pmid:22724516
    OpenUrlCrossRefPubMed
  69. ↵
    1. Pekkonen E
    (2000) Mismatch negativity in aging and in Alzheimer's and Parkinson's diseases. Audiol Neurootol 5:216–224. doi:10.1159/000013883 pmid:10859416
    OpenUrlCrossRefPubMed
  70. ↵
    1. Petersen RC,
    2. Caracciolo B,
    3. Brayne C,
    4. Gauthier S,
    5. Jelic V,
    6. Fratiglioni L
    (2014) Mild cognitive impairment: a concept in evolution. J Intern Med 275:214–228. doi:10.1111/joim.12190 pmid:24605806
    OpenUrlCrossRefPubMed
  71. ↵
    1. Phillips HN,
    2. Blenkmann A,
    3. Hughes LE,
    4. Kochen S,
    5. Bekinschtein TA,
    6. Rowe JB
    , Cambridge Center for Ageing and Neuroscience (2016) Convergent evidence for hierarchical prediction networks from human electrocorticography and magnetoencephalography. Cortex 82:192–205. doi:10.1016/j.cortex.2016.05.001 pmid:27389803
    OpenUrlCrossRefPubMed
  72. ↵
    1. Price D,
    2. Tyler LK,
    3. Neto Henriques R,
    4. Campbell KL,
    5. Williams N,
    6. Treder MS,
    7. Taylor JR,
    8. Henson RNA
    , Cambridge Center for Ageing and Neuroscience (2017) Age-related delay in visual and auditory evoked responses is mediated by white- and grey-matter differences. Nat Commun 8:15671. doi:10.1038/ncomms15671 pmid:28598417
    OpenUrlCrossRefPubMed
  73. ↵
    1. Rietman ML,
    2. van der A DL,
    3. van Oostrom SH,
    4. Picavet HS,
    5. Dollé ME,
    6. van Steeg H,
    7. Verschuren WM,
    8. Spijkerman AM
    (2018) The association between BMI and different frailty domains: a U-shaped curve? J Nutr Health Aging 22:8–15. doi:10.1007/s12603-016-0854-3
    OpenUrlCrossRef
  74. ↵
    1. Robertson DA,
    2. Savva GM,
    3. Kenny RA
    (2013) Frailty and cognitive impairment: a review of the evidence and causal mechanisms. Ageing Res Rev 12:840–851. doi:10.1016/j.arr.2013.06.004 pmid:23831959
    OpenUrlCrossRefPubMed
  75. ↵
    1. Robertson DA,
    2. Savva GM,
    3. Coen RF,
    4. Kenny RA
    (2014) Cognitive function in the prefrailty and frailty syndrome. J Am Geriatr Soc 62:2118–2124. doi:10.1111/jgs.13111
    OpenUrlCrossRefPubMed
  76. ↵
    1. Rogers NT,
    2. Steptoe A,
    3. Cadar D
    (2017) Frailty is an independent predictor of incident dementia: evidence from the English Longitudinal Study of Ageing. Sci Rep 7:15746. doi:10.1038/s41598-017-16104-y pmid:29146957
    OpenUrlCrossRefPubMed
  77. ↵
    1. Ruzzoli M,
    2. Pirulli C,
    3. Mazza V,
    4. Miniussi C,
    5. Brignani D
    (2016) The mismatch negativity as an index of cognitive decline for the early detection of Alzheimer's disease. Sci Rep 6:33167. doi:10.1038/srep33167 pmid:27616726
    OpenUrlCrossRefPubMed
  78. ↵
    1. Schwarz AJ,
    2. Yu P,
    3. Miller BB,
    4. Shcherbinin S,
    5. Dickson J,
    6. Navitsky M,
    7. Joshi AD,
    8. Devous MD,
    9. Mintun MS
    (2016) Regional profiles of the candidate tau PET ligand 18F-AV-1451 recapitulate key features of Braak histopathological stages. Brain 139:1539–1550. doi:10.1093/brain/aww023 pmid:26936940
    OpenUrlCrossRefPubMed
  79. ↵
    1. Shafto MA,
    2. Tyler LK,
    3. Dixon M,
    4. Taylor JR,
    5. Rowe JB,
    6. Cusack R,
    7. Calder AJ,
    8. Marslen-Wilson WD,
    9. Duncan J,
    10. Dalgleish T,
    11. Henson RN,
    12. Brayne C,
    13. Matthews FE
    , Cambridge Center for Ageing and Neuroscience (2014) The Cambridge Centre for Ageing and Neuroscience (Cam-CAN) study protocol: a cross-sectional, lifespan, multidisciplinary examination of healthy cognitive ageing. BMC Neurol 14:204. doi:10.1186/s12883-014-0204-1 pmid:25412575
    OpenUrlCrossRefPubMed
  80. ↵
    1. Shimada H,
    2. Makizako H,
    3. Lee S,
    4. Doi T,
    5. Lee S,
    6. Tsutsumimoto K,
    7. Harada K,
    8. Hotta R,
    9. Bae S,
    10. Nakakubo S,
    11. Harada K,
    12. Suzuki T
    (2016) Impact of cognitive frailty on daily activities in older persons. J Nutr Health Aging 20:729–735. doi:10.1007/s12603-016-0685-2 pmid:27499306
    OpenUrlCrossRefPubMed
  81. ↵
    1. Shimada H,
    2. Makizako H,
    3. Tsutsumimoto K,
    4. Doi T,
    5. Lee S,
    6. Suzuki T
    (2018) Cognitive frailty and incidence of dementia in older persons. J Prev Alzheimers Dis 5:42–48. doi:10.14283/jpad.2017.29 pmid:29405232
    OpenUrlCrossRefPubMed
  82. ↵
    1. Singh-Manoux A,
    2. Marmot MG,
    3. Glymour M,
    4. Sabia S,
    5. Kivimäki M,
    6. Dugravot A
    (2011) Does cognitive reserve shape cognitive decline? Ann Neurol 70:296–304. doi:10.1002/ana.22391 pmid:21563209
    OpenUrlCrossRefPubMed
  83. ↵
    1. Solfrizzi V,
    2. Scafato E,
    3. Frisardi V,
    4. Sancarlo D,
    5. Seripa D,
    6. Logroscino G,
    7. Baldereschi M,
    8. Crepaldi G,
    9. Di Carlo A,
    10. Galluzzo L,
    11. Gandin C,
    12. Inzitari D,
    13. Maggi S,
    14. Pilotto A,
    15. Panza F
    , Italian Longitudinal Study on Aging Working Group (2012) Frailty syndrome and all-cause mortality in demented patients: the Italian Longitudinal Study on Aging. Age (Dordr) 34:507–517. doi:10.1007/s11357-011-9247-z pmid:21519879
    OpenUrlCrossRefPubMed
  84. ↵
    1. Solfrizzi V,
    2. Scafato E,
    3. Seripa D,
    4. Lozupone M,
    5. Imbimbo BP,
    6. D'Amato A,
    7. Tortelli R,
    8. Schilardi A,
    9. Galluzzo L,
    10. Gandin C,
    11. Baldereschi M,
    12. Di Carlo A,
    13. Inzitari D,
    14. Sabbà C,
    15. Logroscino G,
    16. Panza F
    , Italian Longitudinal Study on Aging Working Group (2017a) Reversible cognitive frailty, dementia, and all-cause mortality: the Italian Longitudinal Study on Aging. J Am Med Dir Assoc 18:89.e1–89.e8.
    OpenUrl
  85. ↵
    1. Solfrizzi V,
    2. Scafato E,
    3. Lozupone M,
    4. Seripa D,
    5. Giannini M,
    6. Sardone R,
    7. Bonfiglio C,
    8. Abbrescia DI,
    9. Galluzzo L,
    10. Gandin C,
    11. Baldereschi M,
    12. Di Carlo A,
    13. Inzitari D,
    14. Daniele A,
    15. Sabbà C,
    16. Logroscino G,
    17. Panza F
    , Italian Longitudinal Study on Aging Working Group (2017b) Additive role of a potentially reversible cognitive frailty model and inflammatory state on the risk of disability: the Italian Longitudinal Study on Aging. Am J Geriatr Psychiatry 25:1236–1248. doi:10.1016/j.jagp.2017.05.018 pmid:28689645
    OpenUrlCrossRefPubMed
  86. ↵
    1. Sperling RA,
    2. Bates JF,
    3. Chua EF,
    4. Cocchiarella AJ,
    5. Rentz DM,
    6. Rosen BR,
    7. Schacter DL,
    8. Albert MS
    (2003) fMRI studies of associative encoding in young and elderly controls and mild Alzheimer's disease. J Neurol Neurosurg Psychiatry 74:44–50. doi:10.1136/jnnp.74.1.44 pmid:12486265
    OpenUrlAbstract/FREE Full Text
  87. ↵
    1. Stam CJ,
    2. Jones BF,
    3. Manshanden I,
    4. van Cappellen van Walsum AM,
    5. Montez T,
    6. Verbunt JP,
    7. de Munck JC,
    8. van Dijk BW,
    9. Berendse HW,
    10. Scheltens P
    (2006) Magnetoencephalographic evaluation of resting-state functional connectivity in Alzheimer's disease. Neuroimage 32:1335–1344. doi:10.1016/j.neuroimage.2006.05.033 pmid:16815039
    OpenUrlCrossRefPubMed
  88. ↵
    1. Stern Y
    (2002) What is cognitive reserve? Theory and research application of the reserve concept. J Int Neuropsychol Soc 8:448–460. pmid:11939702
    OpenUrlCrossRefPubMed
  89. ↵
    1. Sugimoto T,
    2. Ono R,
    3. Kimura A,
    4. Saji N,
    5. Niida S,
    6. Toba K,
    7. Sakurai T
    (2019) Cross-sectional association between cognitive frailty and white matter hyperintensity among memory clinic patients. J Alzheimers Dis 72:605–612. doi:10.3233/JAD-190622 pmid:31594230
    OpenUrlCrossRefPubMed
  90. ↵
    1. Talegawkar SA,
    2. Bandinelli S,
    3. Bandeen-Roche K,
    4. Chen P,
    5. Milaneschi Y,
    6. Tanaka T,
    7. Semba RD,
    8. Guralnik JM,
    9. Ferrucci L
    (2012) A higher adherence to a Mediterranean-style diet is inversely associated with the development of frailty in community-dwelling elderly men and women. J Nutr 142:2161–2166. doi:10.3945/jn.112.165498 pmid:23096005
    OpenUrlAbstract/FREE Full Text
  91. ↵
    1. Tsvetanov KA,
    2. Henson RN,
    3. Tyler LK,
    4. Davis SW,
    5. Shafto MA,
    6. Taylor JR,
    7. Williams N
    , Cambridge Center for Ageing and Neuroscience, Rowe JB (2015) The effect of ageing on fMRI: correction for the confounding effects of vascular reactivity evaluated by joint fMRI and MEG in 335 adults. Hum Brain Mapp 36:2248–2269. doi:10.1002/hbm.22768 pmid:25727740
    OpenUrlCrossRefPubMed
  92. ↵
    1. Valentijn SA,
    2. van Boxtel MP,
    3. van Hooren SA,
    4. Bosma H,
    5. Beckers HJ,
    6. Ponds RW,
    7. Jolles J
    (2005) Change in sensory functioning predicts change in cognitive functioning: results from a 6-year follow-up in the Maastricht Aging Study. J Am Geriatr Soc 53:374–380. doi:10.1111/j.1532-5415.2005.53152.x pmid:15743277
    OpenUrlCrossRefPubMed
  93. ↵
    1. Vlahou EL,
    2. Thurm F,
    3. Kolassa IT,
    4. Schlee W
    (2014) Resting-state slow wave power, healthy aging and cognitive performance. Sci Rep 4:5101. doi:10.1038/srep05101 pmid:24869503
    OpenUrlCrossRefPubMed
  94. ↵
    1. Walston J,
    2. McBurnie MA,
    3. Newman A,
    4. Tracy RP,
    5. Kop WJ,
    6. Hirsch CH,
    7. Gottdiener J,
    8. Fried LP
    , Cardiovascular Health Study (2002) Frailty and activation of the inflammation and coagulation systems with and without clinical comorbidities: results from the Cardiovascular Health Study. Arch Intern Med 162:2333–2341. doi:10.1001/archinte.162.20.2333
    OpenUrlCrossRefPubMed
  95. ↵
    1. Weaver JD,
    2. Huang MH,
    3. Albert M,
    4. Harris T,
    5. Rowe JW,
    6. Seeman TE
    (2002) Interleukin-6 and risk of cognitive decline: MacArthur studies of successful aging. Neurology 59:371–378. doi:10.1212/wnl.59.3.371 pmid:12177370
    OpenUrlAbstract/FREE Full Text
  96. ↵
    1. West S,
    2. Bhugra P
    (2015) Emerging drug targets for Aβ and tau in Alzheimer's disease: a systematic review. Br J Clin Pharmacol 80:221–234. doi:10.1111/bcp.12621
    OpenUrlCrossRef
Back to top

In this issue

The Journal of Neuroscience: 42 (7)
Journal of Neuroscience
Vol. 42, Issue 7
16 Feb 2022
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Ed Board (PDF)
Email

Thank you for sharing this Journal of Neuroscience article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Neurophysiological and Brain Structural Markers of Cognitive Frailty Differ from Alzheimer's Disease
(Your Name) has forwarded a page to you from Journal of Neuroscience
(Your Name) thought you would be interested in this article in Journal of Neuroscience.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
View Full Page PDF
Citation Tools
Neurophysiological and Brain Structural Markers of Cognitive Frailty Differ from Alzheimer's Disease
Ece Kocagoncu, David Nesbitt, Tina Emery, Laura E. Hughes, Richard N. Henson, James B. Rowe, Cambridge Center for Ageing and Neuroscience
Journal of Neuroscience 16 February 2022, 42 (7) 1362-1373; DOI: 10.1523/JNEUROSCI.0697-21.2021

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Respond to this article
Request Permissions
Share
Neurophysiological and Brain Structural Markers of Cognitive Frailty Differ from Alzheimer's Disease
Ece Kocagoncu, David Nesbitt, Tina Emery, Laura E. Hughes, Richard N. Henson, James B. Rowe, Cambridge Center for Ageing and Neuroscience
Journal of Neuroscience 16 February 2022, 42 (7) 1362-1373; DOI: 10.1523/JNEUROSCI.0697-21.2021
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Keywords

  • aging
  • Alzheimer's disease
  • cognitive frailty
  • cognitive reserve
  • MEG
  • MRI

Responses to this article

Respond to this article

Jump to comment:

No eLetters have been published for this article.

Related Articles

Cited By...

More in this TOC Section

Research Articles

  • Musical training facilitates exogenous temporal attention via delta phase entrainment within a sensorimotor network
  • Microglial Cytokines Mediate Plasticity Induced by 10 Hz Repetitive Magnetic Stimulation
  • Subgenual and hippocampal pathways in amygdala are set to balance affect and context processing
Show more Research Articles

Neurobiology of Disease

  • Single Systemic Administration of a Gene Therapy Leading to Disease Treatment in Metachromatic Leukodystrophy Arsa Knockout Mice
  • Rapid and Chronic Ethanol Tolerance Are Composed of Distinct Memory-Like States in Drosophila
  • Retinal Dysfunction in a Mouse Model of HCN1 Genetic Epilepsy
Show more Neurobiology of Disease
  • Home
  • Alerts
  • Visit Society for Neuroscience on Facebook
  • Follow Society for Neuroscience on Twitter
  • Follow Society for Neuroscience on LinkedIn
  • Visit Society for Neuroscience on Youtube
  • Follow our RSS feeds

Content

  • Early Release
  • Current Issue
  • Issue Archive
  • Collections

Information

  • For Authors
  • For Advertisers
  • For the Media
  • For Subscribers

About

  • About the Journal
  • Editorial Board
  • Privacy Policy
  • Contact
(JNeurosci logo)
(SfN logo)

Copyright © 2023 by the Society for Neuroscience.
JNeurosci Online ISSN: 1529-2401

The ideas and opinions expressed in JNeurosci do not necessarily reflect those of SfN or the JNeurosci Editorial Board. Publication of an advertisement or other product mention in JNeurosci should not be construed as an endorsement of the manufacturer’s claims. SfN does not assume any responsibility for any injury and/or damage to persons or property arising from or related to any use of any material contained in JNeurosci.